In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
Identifieur interne : 000507 ( Main/Exploration ); précédent : 000506; suivant : 000508In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
Auteurs : Fabian Sanchis-Gomar [États-Unis] ; Carl J. Lavie [États-Unis] ; Carme Perez-Quilis [Espagne] ; Brandon M. Henry [États-Unis] ; Giuseppe Lippi [Italie]Source :
- Mayo Clinic proceedings [ 1942-5546 ] ; 2020.
Descripteurs français
- KwdFr :
- Angiotensines (MeSH), Antagonistes des récepteurs aux angiotensines (usage thérapeutique), Antihypertenseurs (usage thérapeutique), Betacoronavirus (MeSH), Coronavirus (MeSH), Humains (MeSH), Infections à coronavirus (MeSH), Inflammation (traitement médicamenteux), Inhibiteurs de l'enzyme de conversion de l'angiotensine (usage thérapeutique), Pandémies (MeSH), Pneumopathie virale (MeSH).
- MESH :
- traitement médicamenteux : Inflammation.
- usage thérapeutique : Antagonistes des récepteurs aux angiotensines, Antihypertenseurs, Inhibiteurs de l'enzyme de conversion de l'angiotensine.
- Angiotensines, Betacoronavirus, Coronavirus, Humains, Infections à coronavirus, Pandémies, Pneumopathie virale.
English descriptors
- KwdEn :
- Angiotensin Receptor Antagonists (therapeutic use), Angiotensin-Converting Enzyme Inhibitors (therapeutic use), Angiotensins (MeSH), Antihypertensive Agents (therapeutic use), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus (MeSH), Coronavirus Infections (MeSH), Humans (MeSH), Inflammation (drug therapy), Pandemics (MeSH), Pneumonia, Viral (MeSH), SARS-CoV-2 (MeSH).
- MESH :
- chemical , therapeutic use : Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents.
- chemical : Angiotensins.
- drug therapy : Inflammation.
- Betacoronavirus, COVID-19, Coronavirus, Coronavirus Infections, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2.
DOI: 10.1016/j.mayocp.2020.05.003
PubMed: 32622458
PubMed Central: PMC7241409
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.</title><author><name sortKey="Sanchis Gomar, Fabian" sort="Sanchis Gomar, Fabian" uniqKey="Sanchis Gomar F" first="Fabian" last="Sanchis-Gomar">Fabian Sanchis-Gomar</name><affiliation wicri:level="2"><nlm:affiliation>University of Valencia and INCLIVA Biomedical Research Institute, Spain; Stanford University School of Medicine, Stanford, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>University of Valencia and INCLIVA Biomedical Research Institute, Spain; Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Lavie, Carl J" sort="Lavie, Carl J" uniqKey="Lavie C" first="Carl J" last="Lavie">Carl J. Lavie</name><affiliation wicri:level="2"><nlm:affiliation>John Ochsner Heart and Vascular Institute, Ochsner Clinical School The University of Queensland School of Medicine, New Orleans, LA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Louisiane</region></placeName><wicri:cityArea>John Ochsner Heart and Vascular Institute, Ochsner Clinical School The University of Queensland School of Medicine, New Orleans</wicri:cityArea></affiliation></author><author><name sortKey="Perez Quilis, Carme" sort="Perez Quilis, Carme" uniqKey="Perez Quilis C" first="Carme" last="Perez-Quilis">Carme Perez-Quilis</name><affiliation wicri:level="1"><nlm:affiliation>University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>University of Valencia and INCLIVA Biomedical Research Institute, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Henry, Brandon M" sort="Henry, Brandon M" uniqKey="Henry B" first="Brandon M" last="Henry">Brandon M. Henry</name><affiliation wicri:level="2"><nlm:affiliation>The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati</wicri:cityArea></affiliation></author><author><name sortKey="Lippi, Giuseppe" sort="Lippi, Giuseppe" uniqKey="Lippi G" first="Giuseppe" last="Lippi">Giuseppe Lippi</name><affiliation wicri:level="1"><nlm:affiliation>University of Verona, Verona, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>University of Verona, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32622458</idno><idno type="pmid">32622458</idno><idno type="doi">10.1016/j.mayocp.2020.05.003</idno><idno type="pmc">PMC7241409</idno><idno type="wicri:Area/Main/Corpus">000538</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000538</idno><idno type="wicri:Area/Main/Curation">000538</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000538</idno><idno type="wicri:Area/Main/Exploration">000538</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.</title><author><name sortKey="Sanchis Gomar, Fabian" sort="Sanchis Gomar, Fabian" uniqKey="Sanchis Gomar F" first="Fabian" last="Sanchis-Gomar">Fabian Sanchis-Gomar</name><affiliation wicri:level="2"><nlm:affiliation>University of Valencia and INCLIVA Biomedical Research Institute, Spain; Stanford University School of Medicine, Stanford, CA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>University of Valencia and INCLIVA Biomedical Research Institute, Spain; Stanford University School of Medicine, Stanford</wicri:cityArea></affiliation></author><author><name sortKey="Lavie, Carl J" sort="Lavie, Carl J" uniqKey="Lavie C" first="Carl J" last="Lavie">Carl J. Lavie</name><affiliation wicri:level="2"><nlm:affiliation>John Ochsner Heart and Vascular Institute, Ochsner Clinical School The University of Queensland School of Medicine, New Orleans, LA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Louisiane</region></placeName><wicri:cityArea>John Ochsner Heart and Vascular Institute, Ochsner Clinical School The University of Queensland School of Medicine, New Orleans</wicri:cityArea></affiliation></author><author><name sortKey="Perez Quilis, Carme" sort="Perez Quilis, Carme" uniqKey="Perez Quilis C" first="Carme" last="Perez-Quilis">Carme Perez-Quilis</name><affiliation wicri:level="1"><nlm:affiliation>University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>University of Valencia and INCLIVA Biomedical Research Institute, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Henry, Brandon M" sort="Henry, Brandon M" uniqKey="Henry B" first="Brandon M" last="Henry">Brandon M. Henry</name><affiliation wicri:level="2"><nlm:affiliation>The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Ohio</region></placeName><wicri:cityArea>The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati</wicri:cityArea></affiliation></author><author><name sortKey="Lippi, Giuseppe" sort="Lippi, Giuseppe" uniqKey="Lippi G" first="Giuseppe" last="Lippi">Giuseppe Lippi</name><affiliation wicri:level="1"><nlm:affiliation>University of Verona, Verona, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>University of Verona, Verona</wicri:regionArea><wicri:noRegion>Verona</wicri:noRegion></affiliation></author></analytic><series><title level="j">Mayo Clinic proceedings</title><idno type="eISSN">1942-5546</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Angiotensin Receptor Antagonists (therapeutic use)</term><term>Angiotensin-Converting Enzyme Inhibitors (therapeutic use)</term><term>Angiotensins (MeSH)</term><term>Antihypertensive Agents (therapeutic use)</term><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Coronavirus (MeSH)</term><term>Coronavirus Infections (MeSH)</term><term>Humans (MeSH)</term><term>Inflammation (drug therapy)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (MeSH)</term><term>SARS-CoV-2 (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Angiotensines (MeSH)</term><term>Antagonistes des récepteurs aux angiotensines (usage thérapeutique)</term><term>Antihypertenseurs (usage thérapeutique)</term><term>Betacoronavirus (MeSH)</term><term>Coronavirus (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (MeSH)</term><term>Inflammation (traitement médicamenteux)</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (usage thérapeutique)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Angiotensin Receptor Antagonists</term><term>Angiotensin-Converting Enzyme Inhibitors</term><term>Antihypertensive Agents</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Angiotensins</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Inflammation</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Inflammation</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagonistes des récepteurs aux angiotensines</term><term>Antihypertenseurs</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Coronavirus</term><term>Coronavirus Infections</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Angiotensines</term><term>Betacoronavirus</term><term>Coronavirus</term><term>Humains</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32622458</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1942-5546</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>07</Month></PubDate></JournalIssue><Title>Mayo Clinic proceedings</Title><ISOAbbreviation>Mayo Clin Proc</ISOAbbreviation></Journal><ArticleTitle>In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.</ArticleTitle><Pagination><MedlinePgn>1553-1556</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0025-6196(20)30473-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mayocp.2020.05.003</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanchis-Gomar</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Valencia and INCLIVA Biomedical Research Institute, Spain; Stanford University School of Medicine, Stanford, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavie</LastName><ForeName>Carl J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>John Ochsner Heart and Vascular Institute, Ochsner Clinical School The University of Queensland School of Medicine, New Orleans, LA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Quilis</LastName><ForeName>Carme</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Brandon M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lippi</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mayo Clin Proc</MedlineTA><NlmUniqueID>0405543</NlmUniqueID><ISSNLinking>0025-6196</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057911">Angiotensin Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000809">Angiotensins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Mayo Clin Proc. 2020 Jun;95(6):1222-1230</RefSource><PMID Version="1">32376099</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Mayo Clin Proc. 2020 Jul;95(7):1552-1553</RefSource><PMID Version="1">32622456</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D057911" MajorTopicYN="Y">Angiotensin Receptor Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000809" MajorTopicYN="N">Angiotensins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="Y">Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32622458</ArticleId><ArticleId IdType="pii">S0025-6196(20)30473-0</ArticleId><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7241409</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur Heart J. 2005 Feb;26(4):369-75; discussion 322-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15671045</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):757-760</Citation><ArticleIdList><ArticleId IdType="pubmed">32228222</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 2020 Jun 5;126(12):e142-e143</Citation><ArticleIdList><ArticleId IdType="pubmed">32496914</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):825-830</Citation><ArticleIdList><ArticleId IdType="pubmed">32324209</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 2020 Jun;95(6):1222-1230</Citation><ArticleIdList><ArticleId IdType="pubmed">32376099</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Jun 13;13(6):e0198144</Citation><ArticleIdList><ArticleId IdType="pubmed">29897923</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2431-2440</Citation><ArticleIdList><ArticleId IdType="pubmed">32356627</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug Discov Ther. 2020 May 6;14(2):105-106</Citation><ArticleIdList><ArticleId IdType="pubmed">32213760</ArticleId></ArticleIdList></Reference><Reference><Citation>J Travel Med. 2020 May 18;27(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">32186711</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Jun 18;382(25):2441-2448</Citation><ArticleIdList><ArticleId IdType="pubmed">32356628</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Prev Cardiol. 2020 May;27(8):793-796</Citation><ArticleIdList><ArticleId IdType="pubmed">32241182</ArticleId></ArticleIdList></Reference><Reference><Citation>Europace. 2017 Aug 1;19(8):1280-1287</Citation><ArticleIdList><ArticleId IdType="pubmed">27738071</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chim Acta. 2020 Aug;507:167-173</Citation><ArticleIdList><ArticleId IdType="pubmed">32348783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Transl Med. 2016 Nov;4(21):421</Citation><ArticleIdList><ArticleId IdType="pubmed">27942512</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li><li>Italie</li><li>États-Unis</li></country><region><li>Californie</li><li>Louisiane</li><li>Ohio</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Sanchis Gomar, Fabian" sort="Sanchis Gomar, Fabian" uniqKey="Sanchis Gomar F" first="Fabian" last="Sanchis-Gomar">Fabian Sanchis-Gomar</name></region><name sortKey="Henry, Brandon M" sort="Henry, Brandon M" uniqKey="Henry B" first="Brandon M" last="Henry">Brandon M. Henry</name><name sortKey="Lavie, Carl J" sort="Lavie, Carl J" uniqKey="Lavie C" first="Carl J" last="Lavie">Carl J. Lavie</name></country><country name="Espagne"><noRegion><name sortKey="Perez Quilis, Carme" sort="Perez Quilis, Carme" uniqKey="Perez Quilis C" first="Carme" last="Perez-Quilis">Carme Perez-Quilis</name></noRegion></country><country name="Italie"><noRegion><name sortKey="Lippi, Giuseppe" sort="Lippi, Giuseppe" uniqKey="Lippi G" first="Giuseppe" last="Lippi">Giuseppe Lippi</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000507 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000507 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidStanfordV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32622458
|texte= In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32622458" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidStanfordV1
| This area was generated with Dilib version V0.6.38. |  |